1. 128TiP VCN-01 plus durvalumab in subjects with recurrent/metastatic head & neck squamous cell carcinoma (R/M HNSCC): Phase I clinical trial. (15th December 2019) Authors: Jove, M; Braña, I; Taberna, M; Hernando-Calvo, A; Castro, J Brenes; Garralda, E; Serrahima, M Plana; Pujol, M Maños; Capella, G; Alemany, R; Blasi, E; Blasco, C; Piqueras, M Cascallo; Nin, R Mesia Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy. Issue 11 (6th November 2021) Authors: Rovira, A; Tornero, J; Taberna, M; Oliva, M; Montal, R; Nogues, J; Mari, A; Viñals, J M; Lozano, A; Maños, M; Mesia, R Journal: Journal of laryngology & otology Issue: Volume 135:Issue 11(2021) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗